Research ArticleArticle
Toward a Unified Model of Passive Drug Permeation II: The Physiochemical Determinants of Unbound Tissue Distribution with Applications to the Design of Hepatoselective Glucokinase Activators
Avijit Ghosh, Tristan S. Maurer, John Litchfield, Manthema V. Varma, Charles Rotter, Renato Scialis, Bo Feng, Meihua Tu, Cris R. W. Guimaraes and Dennis O. Scott
Drug Metabolism and Disposition October 2014, 42 (10) 1599-1610; DOI: https://doi.org/10.1124/dmd.114.058032
Avijit Ghosh
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
Tristan S. Maurer
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
John Litchfield
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
Manthema V. Varma
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
Charles Rotter
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
Renato Scialis
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
Bo Feng
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
Meihua Tu
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
Cris R. W. Guimaraes
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
Dennis O. Scott
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Toward a Unified Model of Passive Drug Permeation II
Avijit Ghosh, Tristan S. Maurer, John Litchfield, Manthema V. Varma, Charles Rotter, Renato Scialis, Bo Feng, Meihua Tu, Cris R. W. Guimaraes and Dennis O. Scott
Drug Metabolism and Disposition October 1, 2014, 42 (10) 1599-1610; DOI: https://doi.org/10.1124/dmd.114.058032
Research ArticleArticle
Toward a Unified Model of Passive Drug Permeation II
Avijit Ghosh, Tristan S. Maurer, John Litchfield, Manthema V. Varma, Charles Rotter, Renato Scialis, Bo Feng, Meihua Tu, Cris R. W. Guimaraes and Dennis O. Scott
Drug Metabolism and Disposition October 1, 2014, 42 (10) 1599-1610; DOI: https://doi.org/10.1124/dmd.114.058032